Delivery Order SPE2DB24D2216-SPE2DB25FGPPK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a contract ceiling value of $3,691.24. The award was executed on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizing firm fixed-price pricing on a competitive, non-set-aside basis. Performance will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ml syringe format, valued at $3,918.45 under a firm fixed-price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) with a ceiling value of $1,064.40. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Boostrix TDAP vaccine in 0.5ML syringes, with a ceiling value of $7,592.10. This is a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in syringe form (0.5mL) valued at $1,863.95 under a firm fixed price contract. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. Performance of this delivery order will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5ml syringes, with a contract value of $1,890.22. This non-set-aside delivery order, awarded on August 11, 2025, represents a firm fixed-price transaction with an ultimate completion date of August 12, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, serving the company's role as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,064.40 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and the product will be performed and delivered from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,154.61 to supply Boostrix TDAP vaccine syringes (0.5ML) with a firm fixed price structure. The order, issued on August 4, 2025, with completion targeted for August 5, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made without a set-aside designation, indicating competitive procurement through open competition. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringes, valued at approximately $24.9K, with an award date of August 5, 2025 and ultimate completion date of August 6, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under open competition. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $39,915.00 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Boostrix TDAP vaccine syringes (0.5mL). This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents performance at the contractor's Conshohocken, Pennsylvania facility. The award was not designated as a set-aside contract and was competitively awarded to the prime contractor. This delivery order is issued under...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPPKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5ML syringes, with a ceiling value of $2,494.17 under a firm fixed-price contract type. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military and federal healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The current vaccine delivery fulfills critical medical supply requirements within this strategic contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/19/25 |